European Archives - Page 87 of 1446 - European Medical Journal

Sustainability

Pharma's 2025 climate report: ambition to execution

As pharma raced to meet climate targets in 2024-2025, it’s proving that scaling medicines doesn’t have to hurt the planet.

Gut Microbiome Predicts Response to Diabetes Drugs

Importantly, baseline gut microbiome profiles predicted changes in glycohaemoglobin among users of both therapies.

Hospital popping out of mobile phone

TrumpRx: Guidance on DTC sales issued to industry

The Office of Inspector General’s bulletin provides a framework for pharma companies selling prescription drugs direct-to-consumers (DTC).

More Time Outdoors Linked to Higher Testosterone Levels in Men

Spending more time outdoors was linked to higher testosterone levels and lower odds of low testosterone in adult men, independent of lifestyle and metabolic factors.

AI Predicts Antidepressant Treatment Response with 97% Accuracy

Patients who responded to treatment showed increased Beta2 power, enhanced high-frequency functional connectivity, and dominant engagement of frontal brain networks.

Dasatinib Enhances Immune Activation in Philadelphia Leukaemia

Dasatinib plus blinatumomab demonstrated greater and sustained immune activation than ponatinib combinations in Ph+ acute lymphoblastic leukaemia, with marked effects on lymphocytes and natural killer cells.

Lactate Clearance Helps Predict Massive Transfusion in GI Bleeding

New real-world data suggest early lactate clearance can predict massive transfusion needs in upper gastrointestinal bleeding, improving early risk stratification when combined with the Glasgow-Blatchford score.

Nursery Life Reshapes the Infant Microbiome

Babies rapidly share gut microbes at nursery, with peer contact shaping the infant microbiome as strongly as family by the first year of life.

New Guidance Supports HPV Self-Sampling for Cervical Screening

Updated guidance supports HPV self-sampling as an effective way to increase cervical cancer screening uptake among under-screened women.

Evolving Prostate Cancer Therapy: Bertrand Tombal

Evolving Prostate Cancer Therapy: Bertrand Tombal. Chairman, Division of Urology; Full Professor of Urology, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium…..